2006
DOI: 10.1007/s00383-006-1832-3
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic and therapeutic ERCP in the pediatric age group

Abstract: The role and value of endoscopic retrograde cholangiopancreatography (ERCP) in the pediatric age group is not well established, because pancreatic and biliary diseases are less common in children. This however is not the case in areas like the Eastern Province of Saudi Arabia where sickle cell disease (SCD) and other hemoglobinopathies are common, with increased frequency of cholelithiasis and choledocholithiasis. The purpose of this study was to evaluate the indications, findings, safety and therapies of ERCP… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
51
0
1

Year Published

2010
2010
2023
2023

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 83 publications
(56 citation statements)
references
References 23 publications
3
51
0
1
Order By: Relevance
“…Recent pediatric case reviews which incorporate higher proportions of ERCPs performed for pancreatic indications as well as those requiring therapeutic interventions have reported rates of PEP ranging from 2.5% to 9.4%. [12][13][14][15] These rates of PEP are similar to the 1% to 7% commonly cited in the adult literature, which has been more rigorously studied. 16 The rate of PEP experienced in this study (10.9%) is Acute leukoencephalopathy developed during admission, which was also managed only slightly outside these previously reported rates, with mild variations likely related to case mix, operator characteristics, and variations in post-ERCP management.…”
Section: Discussionsupporting
confidence: 61%
“…Recent pediatric case reviews which incorporate higher proportions of ERCPs performed for pancreatic indications as well as those requiring therapeutic interventions have reported rates of PEP ranging from 2.5% to 9.4%. [12][13][14][15] These rates of PEP are similar to the 1% to 7% commonly cited in the adult literature, which has been more rigorously studied. 16 The rate of PEP experienced in this study (10.9%) is Acute leukoencephalopathy developed during admission, which was also managed only slightly outside these previously reported rates, with mild variations likely related to case mix, operator characteristics, and variations in post-ERCP management.…”
Section: Discussionsupporting
confidence: 61%
“…7,8 With regard to the endoscopic procedure, endoscopic sphincterotomy (EST) has been performed for the treatment of BDSs even in pediatric patients, despite possible complications including hemorrhage, pancreatitis, and perforation. 7,[9][10][11] Endoscopic papillary balloon dilation (EPBD), which was first reported in 1983, 12 has the advantages of preserving sphincter of Oddi function and having a lower risk of hemorrhage and perforation compared with EST. 13,14 These advantages raise the possibility that EPBD may be an alternative to EST in the treatment strategy for pediatric patients with BDSs.…”
mentioning
confidence: 99%
“…9 The success rate of ERCP, defined as successfully cannulating the ampula, ranges between 89% and 97%. 10,11 In the hands of a skilled endoscopist, the estimated complication rate for ERCP in children is 3%-5%. 11,12 The most frequently described complication is post-ERCP pancreatitis.…”
Section: Discussionmentioning
confidence: 99%